Allosteric activators of glucokinase: potential role in diabetes therapy
- PMID: 12869762
- DOI: 10.1126/science.1084073
Allosteric activators of glucokinase: potential role in diabetes therapy
Abstract
Glucokinase (GK) plays a key role in whole-body glucose homeostasis by catalyzing the phosphorylation of glucose in cells that express this enzyme, such as pancreatic beta cells and hepatocytes. We describe a class of antidiabetic agents that act as nonessential, mixed-type GK activators (GKAs) that increase the glucose affinity and maximum velocity (Vmax) of GK. GKAs augment both hepatic glucose metabolism and glucose-induced insulin secretion from isolated rodent pancreatic islets, consistent with the expression and function of GK in both cell types. In several rodent models of type 2 diabetes mellitus, GKAs lowered blood glucose levels, improved the results of glucose tolerance tests, and increased hepatic glucose uptake. These findings may lead to the development of new drug therapies for diabetes.
Comment in
-
Medicine. Drug deals diabetes a one-two punch.Science. 2003 Jul 18;301(5631):290. doi: 10.1126/science.301.5631.290. Science. 2003. PMID: 12869732 No abstract available.
Similar articles
-
Novel, highly potent systemic glucokinase activators for the treatment of Type 2 Diabetes Mellitus.Bioorg Med Chem Lett. 2017 May 1;27(9):2069-2073. doi: 10.1016/j.bmcl.2016.10.085. Epub 2016 Oct 31. Bioorg Med Chem Lett. 2017. PMID: 28284804
-
Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus.Mini Rev Med Chem. 2014;14(7):585-602. doi: 10.2174/1389557514666140722082713. Mini Rev Med Chem. 2014. PMID: 25052034 Review.
-
Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects.Handb Exp Pharmacol. 2011;(203):357-401. doi: 10.1007/978-3-642-17214-4_15. Handb Exp Pharmacol. 2011. PMID: 21484579 Review.
-
A novel glucokinase activator modulates pancreatic islet and hepatocyte function.Endocrinology. 2005 Sep;146(9):3696-701. doi: 10.1210/en.2005-0377. Epub 2005 May 26. Endocrinology. 2005. PMID: 15919746
-
Medicine. Drug deals diabetes a one-two punch.Science. 2003 Jul 18;301(5631):290. doi: 10.1126/science.301.5631.290. Science. 2003. PMID: 12869732 No abstract available.
Cited by
-
Clinical investigation of glucokinase activators for the restoration of glucose homeostasis in diabetes.J Diabetes. 2024 May;16(5):e13544. doi: 10.1111/1753-0407.13544. J Diabetes. 2024. PMID: 38664885 Free PMC article. Review.
-
Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Naïve Patients with Type 2 Diabetes Mellitus.Int J Endocrinol. 2023 Dec 27;2023:4996057. doi: 10.1155/2023/4996057. eCollection 2023. Int J Endocrinol. 2023. PMID: 38179187 Free PMC article.
-
Disrupted RNA editing in beta cells mimics early-stage type 1 diabetes.Cell Metab. 2024 Jan 2;36(1):48-61.e6. doi: 10.1016/j.cmet.2023.11.011. Epub 2023 Dec 20. Cell Metab. 2024. PMID: 38128529
-
The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility.Genes (Basel). 2023 Oct 27;14(11):2005. doi: 10.3390/genes14112005. Genes (Basel). 2023. PMID: 38002949 Free PMC article.
-
Insulin C-peptide secretion on-a-chip to measure the dynamics of secretion and metabolism from individual islets.Cell Rep Methods. 2023 Oct 23;3(10):100602. doi: 10.1016/j.crmeth.2023.100602. Epub 2023 Oct 10. Cell Rep Methods. 2023. PMID: 37820726 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical